Jump to content
VA Disability Community via Hadit.com

Ask Your VA   Claims Questions | Read Current Posts 
  
 Read Disability Claims Articles 
 Search | View All Forums | Donate | Blogs | New Users | Rules 

johnc515

Seaman
  • Posts

    11
  • Joined

  • Last visited

About johnc515

Contact Methods

  • Website URL
    http://
  • ICQ
    0

Profile Information

  • Location
    Maryland

Previous Fields

  • Service Connected Disability
    70
  • Branch of Service
    Navy

johnc515's Achievements

  1. This young man is now in Hospice care, god bless him and his family. Please visit his webpage: http://www.caringbridge.org/visit/jordanpaganelli
  2. I know this is not the right place to post this, but I thought I share a local story of a veterans dependent suffering from exposure to toxic smoke in Atsugi, Japan. Link to Article: http://abcnews.go.com/Politics/military-ve...tory?id=8780874 Please visit his Caring bridge page: http://www.caringbridge.org/visit/jordanpaganelli When Laurie Paganelli and her son Jordan, 5, moved to the U.S. Naval Air facility at Atsugi, Japan, in 1997, they felt safe -- free from the dangers of the front lines of war. Little did they know, Paganelli says, a silent killer was lurking above the base, putting the health and safety of her family at risk: A giant plume of toxic smoke, drifting from a nearby Japanese incinerator, floated through the homes where U.S. military families lived and the schoolyards where children, including Jordan, played, experts say. In 1990, a U.S. Department of the Navy document reportedly called the cloud a "witch's brew of toxic chemicals." "It smelled, burned your eyes, and sometimes added a greenish glow to the air around us," Pagnelli told the Senate Committee on Veterans' Affairs today. "We certainly were not aware of the effects it would have on our family years later." On Jan. 11, 2008, doctors diagnosed Jordan, then 16, with a rare and aggressive form of cancer, Alveolar Rhabdo-Myo-Sarcoma (ARMS). Paganelli and several doctors believe Jordan's exposure to the Atsugi incinerator's toxic plume is at least partly to blame for the disease.
  3. Yes, I told the C&P doctor that I was on MTX for both, he even noted that I have seen a "enormous improvement on the skin" since I started taken MTX on my C&P report. The rating letter only mentions this for the arthritis. All of my joints a affected, some are worse such as my wrists and knees. The C&P Doc used the exam work sheets http://www.vba.va.gov/bln/21/Benefits/exams/index.htm for "Shoulder, Elbow, Wrist, Hip, Knee, and Ankle" and "Hand, Thumb, and Fingers". Yes they did X-rays for all joints and used a goniometer to measure the ROM of each joint. He will also ask you alot of questions on how each joint impacts your daily activities, work and how ofen you have flares.
  4. Diablogun, I filed a claim in March 2007 for both Psoriatic Arthritis and psoriasis, I was rated at 60% in May of this year (60% for psoriatic arthritis and 10% for psoriasis). I have filed a NOD because I have taken on Methrotrextate (immunosuppressive drug) every week for the past three years to treat both, if successful my rating for psoriasis should increase to 60%. Also I filed my first claim almost 17 years after my discharge from active duty. Here's what was in my rating letter: Psoriatic Arthritis: We have granted your claim for service connection for your psoriatic arthritis because evidence shows that this disability developed as a result of the inservice psoriasis. We have assigned a 60 percent evaluation effective March 21, 2007, the date we received your claim treatment records from your private physicians show that you have been treated for this condition since early 2006. The records show that you have been treated with methotrexate with significant relief of symptoms. Your disease remains in the active phase. In 2007 you underwent surgery for significant left wrist disability. VA examination shows that both wrists elbows and hands are affected as well as the ankles and feet. You have flares about every month or two lasting for 1 to 2 days, relieved by Celebrex and rest. There is some loss of motion in the elbows, wrists, knees, feet and hips. There is no ankylosis. The hands show boutonniere deformity of all fingers except the thumb and little finger on the left. There is a gap between the finger and proximal transverse crease of hand of the left of 1 to 2 inches. On the right there is no gap. Range of motion of the right thumb is from 0 to 20 degrees and on the left from 0 to 30 degrees. There was no painful motion. The examiner states that this condition is due to the psoriasis incurred during military service. An evaluation of 60 percent is assigned for an active process with weight loss and anemia productive of severe impairment of health, severely incapacitating exacerbations occurring four or more times a year, or a lesser number over prolonged periods. A higher evaluation of 100 percent is not warranted unless there is a totally incapacitating process with constitutional manifestations and active joint involvement. Since there is a likelihood of improvement, the assigned evaluation is not considered permanent and is subject to a future review examination. Psoriasis: We have granted your claim for service connection for psoriasis because service medical records show that this condition began during military service. We have assigned a 10 percent evaluation effective March 21, 2007, the date we received your claim. Your service treatment records show that your psoriasis began on your knees in 1987. Subsequent to service you have continued to receive treatment in the form of topical creams and corticosteroid (Cordran) tape. VA examination shows that currently the psoriasis covers 18 percent of exposed areas and 15 percent of non exposed areas. The face is normal with scaly psoriasiform lesions over the elbows and also the dorsal surface of the hands. The skin on the body is within normal limits. An evaluation of 10 percent is assigned for evidence of at least 5 percent, but less than 20 percent, of the entire body, or at least 5 percent, but less than 20 percent, of exposed areas affected, or; intermittent systemic therapy such as corticosteroids or other immunosuppressive drugs required for a total duration of less than six weeks during the past 12-month period. A higher evaluation of 30 percent is not warranted unless the record shows 20 to 40 percent of the entire body or 20 to 40 percent of exposed areas affected, or; systemic therapy such as corticosteroids or other immunosuppressive drugs required for a total duration of six weeks or more, but not constantly, during the past 12- month period.
×
×
  • Create New...

Important Information

Guidelines and Terms of Use